Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Aug 5.

Published in final edited form as: Gut. 2009 Aug 10;58(12):1597–1605. doi: 10.1136/gut.2009.186361

Fig. 6 — a) Changes in body weight of Rag1−/− mice during 21.5 weeks after transfer of gliadin-presensitized CD4+CD45RBlowCD25− T cells. Immediately after introduction of a gfd at week 10.5 (↑), the diet switch-over group is gaining weight compared to the gliadin/gluten group (***p<0.001). Significantly lower weights in the gliadin/gluten and the diet-switch-over vs. the gliadin/gfd group (⁺⁺⁺p<0.001, °°°p<0.001, n=8–9). b) Exacerbation of histological duodenitis in the gliadin/gluten vs. the gliadin/gfd group at 21.5 weeks (*p<0.05), but non-significant difference for the diet switch-over vs. the gliadin/gfd group (p=0.11, n=8–9). c) Decreased duodenal transcript levels for IFNγ and IL-17A (both *p<0.05), and non-significant decreases for IL-17F (p=0.13) and IL-2 (p=0.15) in the diet switch-over vs. gliadin/gluten group (n=8).

Fig. 6 — a) Changes in body weight of Rag1−/− mice during 21.5 weeks after transfer of gliadin-presensitized CD4+CD45RBlowCD25− T cells. Immediately after introduction of a gfd at week 10.5 (↑), the diet switch-over group is gaining weight compared to the gliadin/gluten group (***p<0.001). Significantly lower weights in the gliadin/gluten and the diet-switch-over vs. the gliadin/gfd group (⁺⁺⁺p<0.001, °°°p<0.001, n=8–9). b) Exacerbation of histological duodenitis in the gliadin/gluten vs. the gliadin/gfd group at 21.5 weeks (*p<0.05), but non-significant difference for the diet switch-over vs. the gliadin/gfd group (p=0.11, n=8–9). c) Decreased duodenal transcript levels for IFNγ and IL-17A (both *p<0.05), and non-significant decreases for IL-17F (p=0.13) and IL-2 (p=0.15) in the diet switch-over vs. gliadin/gluten group (n=8).

HHS Vulnerability Disclosure